Cardiometabolic Diseases
Molecular Basis, Early Detection of Risks, and Management
Herausgeber: Rao, Gundu H R; Das, Undurti N
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Cardiometabolic Diseases
Molecular Basis, Early Detection of Risks, and Management
Herausgeber: Rao, Gundu H R; Das, Undurti N
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Cardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management provides detailed information on all aspects of metabolic dysfunctions and associated risks for cardiometabolic diseases, including a thoughtful discussion of cellular and molecular mechanisms involved in the progression of metabolic risks, approaches for the early detection, and robust management of metabolic risks. Written by a team of expert contributors, this book is useful reading for researchers and clinicians interested on recent advances in etiology of cardiometabolic diseases, the latest noninvasive…mehr
Andere Kunden interessierten sich auch für
- Ipscs for Studying Infectious Diseases174,99 €
- Systems Biology and In-Depth Applications for Unlocking Diseases183,99 €
- Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases181,99 €
- New Approaches to Aortic Diseases from Valve to Abdominal Bifurcation149,99 €
- Patent Foramen Ovale Closure for Stroke, Myocardial Infarction, Peripheral Embolism, Migraine, and Hypoxemia158,99 €
- Recent Advances in Ipscs for Therapy167,99 €
- Effects of Lifestyle on Men's Health143,99 €
-
-
-
Cardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management provides detailed information on all aspects of metabolic dysfunctions and associated risks for cardiometabolic diseases, including a thoughtful discussion of cellular and molecular mechanisms involved in the progression of metabolic risks, approaches for the early detection, and robust management of metabolic risks. Written by a team of expert contributors, this book is useful reading for researchers and clinicians interested on recent advances in etiology of cardiometabolic diseases, the latest noninvasive approaches for diagnosis, risk assessment tools, therapeutic strategies, and also aspects of prevention of cardiometabolic diseases.
Produktdetails
- Produktdetails
- Verlag: Elsevier Science
- Seitenzahl: 350
- Erscheinungstermin: 27. September 2024
- Englisch
- Gewicht: 1520g
- ISBN-13: 9780323954693
- ISBN-10: 0323954693
- Artikelnr.: 69732372
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Elsevier Science
- Seitenzahl: 350
- Erscheinungstermin: 27. September 2024
- Englisch
- Gewicht: 1520g
- ISBN-13: 9780323954693
- ISBN-10: 0323954693
- Artikelnr.: 69732372
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Preface
Foreword
I. Cardiometabolic Diseases
1. Cardiometabolic Diseases: Risk Factors and Novel Approaches for the
Management of Risks.
2. The Chennai Urban Rural Epidemiology Study (CURES) - A Compendium of
type 2 diabetes in urban Asian Indians: Lessons Learnt
3. Prevalence of diabetes in urban and rural India-ICMR-INDIAB study
4. Burden of cardiometabolic syndrome in children.
5. Diabetes care program with limited resources
6. Type 2 diabetes: A Modern-Day Avatar of Malnutrition Related Diabetes
7. Understanding double burden of malnutrition from a DOHaD perspective:
Review of Mysore Cohorts
8. Diabetes care for the bottom of the socioeconomic pyramid: Four decades
of science, medicine, creativity and empathy (Samatvam India model)
9. Pathophysiology of Cardiorenal Syndrome
10. Evidence of Clinical Trials of Cardiac Outcomes on Renal Disease
II. CMDs: Cellular Mechanisms
11. Periodontal Disease and Occlusive Atherosclerotic Vascular Diseases
12. Insulin is a cytoprotective molecule
13. Galectin-3 and its associated molecular partners in the emergence and
progression of cardiometabolic disorders
14. Vascular Dysfunction in Obesity and Diabetes: Role of ncRNA
15. In-Cardiome: Integrated knowledge base for CAD Enabling Translational
Research
16. Are Southeast Asians Cushingoid? A molecular explanation for the high
incidence of metabolic
syndrome
17. Occlusive Arterial Vascular Diseases: Cellular and Molecular Mechanisms
18. Why is exercise beneficial?
III. Risk Factors and Prevention
19. Hypothyroidism, Diabetes and Cardiovascular disease
20. Adipose Tissue and Dyslipidemia: Insight from Lipodystrophy Syndromes -
why fat is not the enemy in Cardiometabolic disease
21. Risk Factors for Ischemic Stroke
22. Blood pressure lowering in kidney disease
23. Diabetic Peripheral Vascular Disease.
24. Limb salvage among people with Diabetes.
25. The role of Blood Viscosity in Health and Disease
26. Hypertension and Acute coronary Syndromes
27. Hypertension and Stroke: An Update
28. Prevention of Childhood Obesity and Diabetes : An Indian Context
29. Screening of cardiovascular risk in school children and adolescents
30. Diabetes Pandemic in Manitoba: An Update on Prevention of New Cases
31. Type 1 diabetes risk factors and prevention
32. Cardiovascular Risk Stratification in Indian Subjects: Lessons Learned
and the Way Forward
33. Measurement of Carotid Plaque Burden.
34. Role of Metabolic State, Hemodynamics, and Neuromonitoring in Cardiac
Arrest Survival and Neurological Outcome
35. Secondary Stroke Prevention
36. Acute Ischemic Stroke: Diagnosis and Endovascular Management
37. Cardiometabolic Diseases - Recent Advance in Antithrombotic and
Thrombolytic Therapies
38. Management of Cardio-Metabolic Diseases: A Clinician's Perspective
39. Prevention of Cardiovascular Diseases - From Science to Public Health
Action
Foreword
I. Cardiometabolic Diseases
1. Cardiometabolic Diseases: Risk Factors and Novel Approaches for the
Management of Risks.
2. The Chennai Urban Rural Epidemiology Study (CURES) - A Compendium of
type 2 diabetes in urban Asian Indians: Lessons Learnt
3. Prevalence of diabetes in urban and rural India-ICMR-INDIAB study
4. Burden of cardiometabolic syndrome in children.
5. Diabetes care program with limited resources
6. Type 2 diabetes: A Modern-Day Avatar of Malnutrition Related Diabetes
7. Understanding double burden of malnutrition from a DOHaD perspective:
Review of Mysore Cohorts
8. Diabetes care for the bottom of the socioeconomic pyramid: Four decades
of science, medicine, creativity and empathy (Samatvam India model)
9. Pathophysiology of Cardiorenal Syndrome
10. Evidence of Clinical Trials of Cardiac Outcomes on Renal Disease
II. CMDs: Cellular Mechanisms
11. Periodontal Disease and Occlusive Atherosclerotic Vascular Diseases
12. Insulin is a cytoprotective molecule
13. Galectin-3 and its associated molecular partners in the emergence and
progression of cardiometabolic disorders
14. Vascular Dysfunction in Obesity and Diabetes: Role of ncRNA
15. In-Cardiome: Integrated knowledge base for CAD Enabling Translational
Research
16. Are Southeast Asians Cushingoid? A molecular explanation for the high
incidence of metabolic
syndrome
17. Occlusive Arterial Vascular Diseases: Cellular and Molecular Mechanisms
18. Why is exercise beneficial?
III. Risk Factors and Prevention
19. Hypothyroidism, Diabetes and Cardiovascular disease
20. Adipose Tissue and Dyslipidemia: Insight from Lipodystrophy Syndromes -
why fat is not the enemy in Cardiometabolic disease
21. Risk Factors for Ischemic Stroke
22. Blood pressure lowering in kidney disease
23. Diabetic Peripheral Vascular Disease.
24. Limb salvage among people with Diabetes.
25. The role of Blood Viscosity in Health and Disease
26. Hypertension and Acute coronary Syndromes
27. Hypertension and Stroke: An Update
28. Prevention of Childhood Obesity and Diabetes : An Indian Context
29. Screening of cardiovascular risk in school children and adolescents
30. Diabetes Pandemic in Manitoba: An Update on Prevention of New Cases
31. Type 1 diabetes risk factors and prevention
32. Cardiovascular Risk Stratification in Indian Subjects: Lessons Learned
and the Way Forward
33. Measurement of Carotid Plaque Burden.
34. Role of Metabolic State, Hemodynamics, and Neuromonitoring in Cardiac
Arrest Survival and Neurological Outcome
35. Secondary Stroke Prevention
36. Acute Ischemic Stroke: Diagnosis and Endovascular Management
37. Cardiometabolic Diseases - Recent Advance in Antithrombotic and
Thrombolytic Therapies
38. Management of Cardio-Metabolic Diseases: A Clinician's Perspective
39. Prevention of Cardiovascular Diseases - From Science to Public Health
Action
Preface
Foreword
I. Cardiometabolic Diseases
1. Cardiometabolic Diseases: Risk Factors and Novel Approaches for the
Management of Risks.
2. The Chennai Urban Rural Epidemiology Study (CURES) - A Compendium of
type 2 diabetes in urban Asian Indians: Lessons Learnt
3. Prevalence of diabetes in urban and rural India-ICMR-INDIAB study
4. Burden of cardiometabolic syndrome in children.
5. Diabetes care program with limited resources
6. Type 2 diabetes: A Modern-Day Avatar of Malnutrition Related Diabetes
7. Understanding double burden of malnutrition from a DOHaD perspective:
Review of Mysore Cohorts
8. Diabetes care for the bottom of the socioeconomic pyramid: Four decades
of science, medicine, creativity and empathy (Samatvam India model)
9. Pathophysiology of Cardiorenal Syndrome
10. Evidence of Clinical Trials of Cardiac Outcomes on Renal Disease
II. CMDs: Cellular Mechanisms
11. Periodontal Disease and Occlusive Atherosclerotic Vascular Diseases
12. Insulin is a cytoprotective molecule
13. Galectin-3 and its associated molecular partners in the emergence and
progression of cardiometabolic disorders
14. Vascular Dysfunction in Obesity and Diabetes: Role of ncRNA
15. In-Cardiome: Integrated knowledge base for CAD Enabling Translational
Research
16. Are Southeast Asians Cushingoid? A molecular explanation for the high
incidence of metabolic
syndrome
17. Occlusive Arterial Vascular Diseases: Cellular and Molecular Mechanisms
18. Why is exercise beneficial?
III. Risk Factors and Prevention
19. Hypothyroidism, Diabetes and Cardiovascular disease
20. Adipose Tissue and Dyslipidemia: Insight from Lipodystrophy Syndromes -
why fat is not the enemy in Cardiometabolic disease
21. Risk Factors for Ischemic Stroke
22. Blood pressure lowering in kidney disease
23. Diabetic Peripheral Vascular Disease.
24. Limb salvage among people with Diabetes.
25. The role of Blood Viscosity in Health and Disease
26. Hypertension and Acute coronary Syndromes
27. Hypertension and Stroke: An Update
28. Prevention of Childhood Obesity and Diabetes : An Indian Context
29. Screening of cardiovascular risk in school children and adolescents
30. Diabetes Pandemic in Manitoba: An Update on Prevention of New Cases
31. Type 1 diabetes risk factors and prevention
32. Cardiovascular Risk Stratification in Indian Subjects: Lessons Learned
and the Way Forward
33. Measurement of Carotid Plaque Burden.
34. Role of Metabolic State, Hemodynamics, and Neuromonitoring in Cardiac
Arrest Survival and Neurological Outcome
35. Secondary Stroke Prevention
36. Acute Ischemic Stroke: Diagnosis and Endovascular Management
37. Cardiometabolic Diseases - Recent Advance in Antithrombotic and
Thrombolytic Therapies
38. Management of Cardio-Metabolic Diseases: A Clinician's Perspective
39. Prevention of Cardiovascular Diseases - From Science to Public Health
Action
Foreword
I. Cardiometabolic Diseases
1. Cardiometabolic Diseases: Risk Factors and Novel Approaches for the
Management of Risks.
2. The Chennai Urban Rural Epidemiology Study (CURES) - A Compendium of
type 2 diabetes in urban Asian Indians: Lessons Learnt
3. Prevalence of diabetes in urban and rural India-ICMR-INDIAB study
4. Burden of cardiometabolic syndrome in children.
5. Diabetes care program with limited resources
6. Type 2 diabetes: A Modern-Day Avatar of Malnutrition Related Diabetes
7. Understanding double burden of malnutrition from a DOHaD perspective:
Review of Mysore Cohorts
8. Diabetes care for the bottom of the socioeconomic pyramid: Four decades
of science, medicine, creativity and empathy (Samatvam India model)
9. Pathophysiology of Cardiorenal Syndrome
10. Evidence of Clinical Trials of Cardiac Outcomes on Renal Disease
II. CMDs: Cellular Mechanisms
11. Periodontal Disease and Occlusive Atherosclerotic Vascular Diseases
12. Insulin is a cytoprotective molecule
13. Galectin-3 and its associated molecular partners in the emergence and
progression of cardiometabolic disorders
14. Vascular Dysfunction in Obesity and Diabetes: Role of ncRNA
15. In-Cardiome: Integrated knowledge base for CAD Enabling Translational
Research
16. Are Southeast Asians Cushingoid? A molecular explanation for the high
incidence of metabolic
syndrome
17. Occlusive Arterial Vascular Diseases: Cellular and Molecular Mechanisms
18. Why is exercise beneficial?
III. Risk Factors and Prevention
19. Hypothyroidism, Diabetes and Cardiovascular disease
20. Adipose Tissue and Dyslipidemia: Insight from Lipodystrophy Syndromes -
why fat is not the enemy in Cardiometabolic disease
21. Risk Factors for Ischemic Stroke
22. Blood pressure lowering in kidney disease
23. Diabetic Peripheral Vascular Disease.
24. Limb salvage among people with Diabetes.
25. The role of Blood Viscosity in Health and Disease
26. Hypertension and Acute coronary Syndromes
27. Hypertension and Stroke: An Update
28. Prevention of Childhood Obesity and Diabetes : An Indian Context
29. Screening of cardiovascular risk in school children and adolescents
30. Diabetes Pandemic in Manitoba: An Update on Prevention of New Cases
31. Type 1 diabetes risk factors and prevention
32. Cardiovascular Risk Stratification in Indian Subjects: Lessons Learned
and the Way Forward
33. Measurement of Carotid Plaque Burden.
34. Role of Metabolic State, Hemodynamics, and Neuromonitoring in Cardiac
Arrest Survival and Neurological Outcome
35. Secondary Stroke Prevention
36. Acute Ischemic Stroke: Diagnosis and Endovascular Management
37. Cardiometabolic Diseases - Recent Advance in Antithrombotic and
Thrombolytic Therapies
38. Management of Cardio-Metabolic Diseases: A Clinician's Perspective
39. Prevention of Cardiovascular Diseases - From Science to Public Health
Action